Quantum dot (QD) nanoparticles have potential applications in nanomedicine as drug delivery vectors and diagnostic agents, but the skin toxicity and irritation potential of QDs are unknown. Human epidermal keratinocytes (HEKs) were used to assess if QDs with different surface coatings would cause differential effects on HEK cytotoxicity, proinflammatory cytokine release, and cellular uptake. Commercially available QDs of two different sizes, QD 565 and QD 655, with neutral (polyethylene glycol (PEG)), cationic (PEG-amine), or anionic (carboxylic acid) coatings were utilized. Live cell imaging and transmission electron microscopy were used to determine that all QDs localized intracellularly by 24 hours, with evidence of QD localization in the nucleus. Cytotoxicity and release of the proinflammatory cytokines IL-1b, IL-6, IL-8, IL-10, and tumor necrosis factor-a were assessed at 24 and 48 hours. Cytotoxicity was observed for QD 565 and QD 655 coated with carboxylic acids or PEG-amine by 48 hours, with little cytotoxicity observed for PEG-coated QDs. Only carboxylic acidcoated QDs significantly increased release of IL-1b, IL-6, and IL-8. These data indicate that QD surface coating is a primary determinant of cytotoxicity and immunotoxicity in HEKs, which is consistent across size. However, uptake of QDs by HEKs is independent of surface coating.
INTRODUCTION
Semiconductor nanocrystals, or quantum dots (QDs) have great potential for use as drug delivery, diagnostic, and imaging agents in biomedicine and as semiconductors in the electronics industry. QDs are a diverse class of engineered nanostructures that are highly variable in chemical composition, size, and shape and are frequently multi-layered. The center is comprised of a heterogeneous, colloidal core of inorganic atoms (e.g., CdSe, CdTe, InAs, GaN) that is frequently surrounded by a shell or ''cap'', such as ZnS, that can reduce leaching of core metals (Derfus et al., 2004) and attenuate fluorescence intermittency, or ''blinking'' (Nirmal et al., 1996) . Surface coatings in one or more layers are often applied to the core/shell complex to customize QDs for different applications, such as increased solubility in biological media or bioconjugation to antibodies or receptor ligands for ''targeted'' drug delivery and diagnostics (Michalet et al., 2005) . Nanoscale materials possess novel properties as a direct consequence of size. This may have unique consequences for toxicology (Monteiro-Riviere and Ryman-Rasmussen, 2006) . The hallmark nanoscale property of QDs is quantum confinement, in which the distance between an excited electron in the conduction band and the corresponding vacant hole in the valence band (the ''Bohr radius'') is greater than the size of the nanocrystal core, which results in fluorescence at size-dependent wavelengths. The excitation range of QDs is broad but the fluorescence is discreet and resistant to photobleaching, making QDs easily detectable and amenable to multicolor imaging studies and tracking in live cells.
A seminal study demonstrated that targeted CdSe core/ZnS shell QDs could be internalized by HeLa cells and tracked in live cells for more than 10 days with no morphological signs of toxicity (Jaiswal et al., 2003) . This study fueled a great deal of optimism that QDs were non-toxic at doses suitable for long-term imaging studies and drug delivery. Therefore, many synthetic efforts were focused in these directions. There are increasing reports of QD cytotoxicity in the literature (Hardman, 2006) , none of which address skin. Recently, we reported that exposure of skin to commercially available QDs differing in core/shell shape, hydrodynamic size, and surface coatings resulted in the penetration of the intact stratum corneum barrier with localization of QDs in the underlying epidermal and dermal layers as early as 8 hours after topical application . This indicated that skin is a potential route of exposure to QDs.
The present study utilized primary human neonatal epidermal keratinocytes (HEKs), an established in vitro model for epidermal toxicity, to determine the cytotoxic and inflammatory potential of QDs in skin. This study was designed to test the hypothesis that QDs would be differentially taken up by HEKs and cause cytotoxicity and inflammatory cytokine release in a manner dependent on surface coating. Soluble QDs of two sizes, QD 565 and QD 655, were obtained from a single, commercial source. Both QD 565 and QD 655 were obtained with three different surface coatings: polyethylene glycol (PEG), PEG-amines, or carboxylic acids. We used laser scanning confocal microscopy of live keratinocytes and transmission electron microscopy (TEM) to verify QD uptake 24 hours after administration. Cytotoxicity was assessed by cell viability assays with thiazolyl blue tetrazolium bromide (3- [4, 5] dimethylthiazol-2,5 dephenyltetrazolium bromide (MTT)) at 24 and 48 hours. Inflammatory potential was assessed at 24 and 48 hours by measuring the release of the proinflammatory cytokines IL-1b, IL-6, IL-8, IL-10, and tumor necrosis factor-a that are often used as markers for cutaneous irritation.
RESULTS

Laser scanning confocal microscopy of QDs in live HEKs at 24 hours
We observed no overlap in the emission channels for QD 565 (green) and QD 655 (red) in trials with fixed keratinocytes treated with 2 nM QD 565 or QD 655, which indicated that dual-label imaging experiments were valid at this concentration, and autofluorescence in the absence of QDs was negligible (data not shown). QDs of both sizes and all coatings were localized intracellularly by 24 hours (Figure 1 ). Punctate staining of PEG-coated QD 565 and QD 655 (Figure 1 , top row) was observed in the cytoplasm, at the periphery of the nucleus, and in the nucleus (QD 565). There was no evidence of PEG-coated QD 565 and QD 655 colocalization (orange), although there were instances of individual cells that contained both green and red punctae. Approximately 50% of HEK cells in any visual field contained PEG-coated QDs. PEG-amine-coated QD 565 and QD 655 (Figure 1 , middle row) were observed as very large green (QD 565) or red (QD 655) 
TEM of QDs in HEKs at 24 hours
QDs of both sizes and all coatings were intracellularly localized by 24 hours. In all cases, QDs were usually found agglomerated, both in membrane-bound, vacuolar compartments ( Figure 2a ) or free in the cytoplasm (Figure 2b ). Occasionally with the PEG and PEG-amine-coated QD 565, we observed lipid droplets that were peppered with QDs in the interior and more dense along the periphery (Figure 2c ). We also observed several instances for PEG-coated QD 565 and QD 655 and carboxylic acid-coated QD 565 in which QDs were agglomerated within the intranuclear region of the cells. (Figure 2d ).
MTT cell viability assays at 24 and 48 hours
No effects of 5% (v/v) borate vehicle of pH 8.3 or 9.0 were seen on HEK viability at 24 or 48 hours (Figure 3a ). No differences in HEK viability were observed for three concentrations of PEG-coated QD 565 at 24 or 48 hours (Figure 3b ). No differences were observed for PEG-coated QD 655 at 24 hours. At 48 hours, however, there was a moderate (20%) but significant decrease in MTT viability at 20 nM compared to vehicle-treated controls and lower concentrations.
No differences in viability at any of the three concentrations were observed for PEG-amine-coated QD 565 at 24 hours (Figure 3c ). At 48 hours, however, viability decreased by 40% at the highest concentration compared to vehicle-treated controls and lower concentrations. As cytotoxicity was present at 48 hours but not 24 hours, we statistically compared viability at 24 and 48 hours at 20 nM and found a significant effect of time on viability. Similarly, for QD 655 coated with PEG-amine, there were no dosedependent differences in viability at 24 hours. However, at 48 hours, viability at 20 nM was decreased to 40% compared to vehicle-treated controls and lower concentrations. There was also a significant effect of time on the cytotoxicity of PEGamine-coated QD 655 at 20 nM between 24 and 48 hours.
Unlike QD 565 coated with PEG or PEG-amines, there were significant differences in HEK viability at 24 hours for carboxylic acid-coated QD 565 (Figure 3d ). HEKs treated at the highest of the three concentrations (20 nM) showed a 40% decrease in viability compared to vehicle-treated controls and lower concentrations. These differences remained at 48 hours. Similarly, QD 655 coated with carboxylic acids decreased HEK viability by 40% at 24 hours compared to vehicle-treated controls and lower concentrations. These differences remained at 48 hours, where viability was decreased by another 30%. This decrease in viability between 24 and 48 hours was significant and indicated an effect of time on cytotoxicity. As the decrease in viability between 24 and 48 hours for carboxylic acid-coated QD 565 was smaller than QD 655, we conducted statistical comparisons to see if there was an effect of size on the cytotoxicity. Comparison at 24 hours revealed no size differences. However, viability for QD 655 was significantly decreased relative to QD 565 at 48 hours, indicating a modulatory role for size in cytotoxicity.
Cytokines
For all detectable cytokines, there were no effects of 5% (v/v) borate vehicle pH 8.3 or 9.0 at 24 or 48 hours.
IL-10 and tumor necrosis factor-a IL-10 and tumor necrosis factor-a release were not detectable for QD 565 and QD 655 of any coating at 24 or 48 hours within the low range of the multiplex assay, which had a threshold of 0.78 pg/ml.
IL-1b
The basal, control levels of IL-1b in the culture medium at 24 hours averaged 1.170.2 and 2.670.7 pg/ml at maximal www.jidonline.org 145 response to QDs. Basal levels at 48 hours averaged 2.670.6 and 12.272.6 pg/ml at maximal response to QDs (data not shown).
Effects of dose and coating on IL-1b release were observed for QD 565. At 24 hours, there was over a 2-fold, dosedependent increase in IL-1b release for carboxylic acidcoated QD 565 (Figure 4b ). IL-1b release for this coating was also significantly elevated compared to PEG and PEG-amine coatings at either dose. These differences remained at 48 hours (Figure 4c ). The magnitude of IL-1b release for carboxylic acid-coated QD 565 did not change between 24 and 48 hours (Figure 4d ).
Effects of coating and time on IL-1b release were observed for QD 655. At 24 hours, there was over a 3-fold, dosedependent increase in IL-1b release for carboxylic acidcoated QD 655 (Figure 4b ). This was significantly elevated compared to QD 655 coated with PEG or PEG-amines. At 48 hours, the magnitude of IL-1b release carboxylic acidcoated QD 655 at the highest dose exceeded controls, the lower dose, and other coatings by over 5-fold (Figure 4c ). Comparison of IL-1b levels for 20 nM carboxylic acid-coated QD 655 at 24 and 48 hours revealed a significant effect of time on the magnitude of IL-1b release for this coating and dose (Figure 4d ).
At 48 hours, the difference in IL-1b release for 20 nM carboxylic acid-coated QD 655 and QD 565 was greater than 2-fold ( Figure 4c ). Statistical analysis confirmed that this difference was significant, revealing an effect of size on IL-1b release.
IL-6
The basal, control levels of IL-6 in the culture medium at 24 hours averaged 110730 and 220780 pg/ml at maximal response to QDs. Basal levels at 48 hours averaged 130750 and 260770 at maximal response to QDs (data not shown).
Effects of dose and coating were observed for QD 565. At 24 hours, IL-6 release for carboxylic acid-coated QD 565 at 20 nM was over 50% greater than control and the lower dose (Figure 5b ). At 48 hours, 20 nM carboxylic acid-coated QD 565 was elevated 2-fold compared to controls, the lower dose, and PEG coating at either dose ( Figure 5c ). There was also a slight but significant dose-dependent elevation in IL-6 release for 20 nM PEG-amine-coated QD 565 compared to controls and the lower dose. IL-6 release for carboxylic acidcoated QD 565 did not significantly differ between 24 and 48 hours (Figure 5d ).
IL-6 release for QD 655 was dependent on dose, coating, and time. Unlike QD 565, there were no effects of coating or concentration on IL-6 release for QD 655 at 24 hours ( Figure  5b ). However, significant differences were apparent at 48 hours ( Figure 5c ). Carboxylic acid-coated QD 655 at the highest dose was elevated 2-fold compared to vehicle-treated controls, the lower dose, and PEG and PEG-amine-coated QD 655 at both doses. Comparison of the magnitude of IL-6 release for 20 nM carboxylic acid-coated QD 655 at 24 and 48 hours revealed a significant effect of time ( Figure 5d ). The significant increase in IL-6 release at 24 hours for 20 nM carboxylic acid-coated QD 565 but not QD 655 indicated an effect of QD size on IL-6 release at 24 hours ( Figure 5b ). This effect was confirmed by statistical comparison. In contrast, at 48 hours, IL-6 release for carboxylic acidcoated QD 565 and QD 655 did not significantly differ ( Figure 5c ).
IL-8
The basal, control levels of IL-8 in the culture medium at 24 hours averaged 1,3007430 and 3,0007600 pg/ml at maximal response to QDs. Basal levels at 48 hours averaged 1,4007140 and 2,8007480 pg/ml at maximal response to QDs (data not shown).
Effects of dose and coating were observed for QD 565. At 24 hours, IL-8 release for 20 nM carboxylic acid-coated QD 565 was 2-fold greater than for vehicle-treated controls, the lower dose, and PEG and PEG-amine coatings at either concentration (Figure 6b ). Forty-eight hours after treatment, the magnitude of IL-8 release for 20 nM carboxylic acidcoated QD 565 was unchanged (Figure 6d ). Also, there was a slight but significant, dose-dependent increase in IL-8 release for 20 nM PEG-amine-coated QD 565 (Figure 6c) .
Effects of coating, dose, and time on IL-8 release were observed in response to QD 655. There were no effects of coating or dose on IL-8 release for QD 655 at 24 hours ( Figure  6b ). By 48 hours, however, significant differences were apparent. IL-8 release for carboxylic acid-coated QD 655 at the highest dose was elevated over 2-fold compared to vehicle-treated controls, the lower dose, and PEG and PEGamine-coatings at either dose. Also, there was a slight but significant dose-dependent increase in IL-8 release for 20 nM PEG-amine-coated QDs. Comparison of IL-8 levels for 20 nM carboxylic acid-coated QD 655 at 24 and 48 hours revealed a significant effect of time on IL-8 release (Figure 6d ). www.jidonline.org 147
An effect of size on IL-8 release for 20 nM carboxylic acidcoated QDs at 24 hours was indicated by the significant increase in the release of this cytokine for QD 565 but not QD 655 (Figure 6b ). This effect was confirmed by statistical comparison. However, this effect of size did not extend to 48 hours, at which time the magnitude of IL-8 release for carboxylic acid-coated QD 565 and QD 655 did not differ (Figure 6c ).
DISCUSSION
We used commercially available CdSe core/ZnS shell QDs of two sizes (QD 565 and QD 655) and three different surface coatings (PEG, PEG-amines, and carboxylic acids) to test the hypothesis that QDs would be differentially taken up by HEKs and cause cytotoxicity and inflammatory cytokine release depending on surface coating. We controlled for potential core-related effects by restricting these studies to QDs of the same core material with defined sizes and surface coatings. We found that all QDs tested localized to the interior of HEKs by 24 hours. However, cytotoxicity and proinflammatory cytokine release were dependent up surface coating, a robust finding consistent across QDs of two different sizes (Table 1) .
Previously, we reported that multi-walled carbon nanotubes were intracellularly localized in cytoplasmic vacuoles of HEKs (Monteiro-Riviere et al., 2005b) . The present study is the first to determine that a similar phenomenon extends to QDs in HEKs. Live cell imaging that eliminates fixation artifacts was used in conjunction with confocal laser scanning microscopy for this purpose. A low (2 nM), noncytotoxic concentration of QDs was chosen to minimize uptake attributable to cell damage. All QDs localized intracellularly by 24 hours, which was surprising because these QDs were not ''targeted'' for cellular delivery. No evidence of colocalization was seen for QD 565 and QD 655 coated with PEG, which indicates that QDs with the same coating, but different core sizes, are differentially trafficked in HEKs. This result is consistent with a previous study, which showed that core size can influence the intracellular localization of QDs with the same coating (Lovric et al., 2005a) . In contrast, QD 565 and QD 655 coated with carboxylic acids or PEG-amines exhibited colocalization, which indicates cellular uptake and/or intracellular trafficking of QD 565 and QD 655 of the same coating by the same mechanisms. The result that QDs of different sizes and coatings localized to the interior of HEKs is of importance because it suggests a mechanism by which QDs may lodge in the avascular epidermis and escape removal by resident macrophages (Monteiro-Riviere and Inman, 2005).
We also observed nuclear localization of carboxylic acid and PEG-coated QDs by live cell confocal laser scanning microscopy, which was confirmed by TEM. Presently, it is not known if nuclear access of the QDs examined in this study would cause genetic damage in HEKs. There is one report, however, that CdSe core/ZnS shell QDs coated with biotin can nick supercoiled DNA in an in vitro, cell-free assay (Green and Howman, 2005) .
Agglomeration and/or adsorption of proteins in the culture medium could modulate QD uptake into cells. TEM revealed agglomeration of QDs within HEKs. Agglomeration may occur in the culture medium as a result of nanoparticle interaction with media salts or proteins (Borm et al., 2006) , which in the case of partially defined keratinocyte growth medium-2 (KGM-2) medium are human epidermal growth factor, insulin, transferrin and peptide hormones, and proteins from bovine pituitary extract. Alternatively, agglomeration may take place in cytoplasmic vacuoles. However, where agglomeration occurs, QDs were clearly available to the cell for uptake, as evidenced by the presence of these agglomerates in vacuoles and free in the cytoplasm for all QDs. Observation of free QDs in the cytoplasm is an important result, suggesting that QDs can escape cytoplasmic vacuoles or elude sequestration, which might allow interactions with cellular organelles or access to the nucleus. Occasionally, we noted the presence of lipid droplets peppered with electron-dense, PEG-and PEG-amine-coated QDs within the interior and along the periphery of the lipid droplet. Such lipids droplets are normally present in HEKs.
Cell viability dose-response assays showed significant cytotoxicity for PEG-amine-and carboxylic acid-coated QDs, but not PEG-coated QDs. These results were consistent www.jidonline.org 149
for QDs of both sizes. PEG-coated QD 565 and QD 655 exhibited no appreciable cytotoxicity over 48 hours, but PEG-amine and carboxylic acid-coated QD 565 and QD 655 exhibited significant cytotoxicity within 48 hours at the highest dose. A modulatory role for exposure time in QD cytotoxicity was demonstrated by comparison of PEG-aminecoated QD 565 and QD 655 at 24 and 48 hours. No decreases in cell viability were observed at 24 hours, but cell viability had decreased significantly by 48 hours in both cases. We also observed a modest but significant effect of QD size on cytotoxicity when carboxylic acid-coated QD 655 exhibited an increase in cytotoxicity between 24 and 48 hours that was greater in magnitude than that observed for QD 565 with the same coating. The cytotoxicity of compositionally diverse QDs has been investigated in multiple cell lines and at multiple end points (Hardman, 2006; Monteiro-Riviere and Ryman-Rasmussen, 2006) . Assessment of QD cytotoxicity at the MTT end point has been reported in several cell lines (Derfus et al., 2004; Shiosahara et al., 2004; Lovric et al., 2005a, b) , but the mechanisms underlying cytotoxicity have not been defined. Hypothesized mechanisms include oxidative stress as a result of QD-mediated reactive oxygen species production (Lovric et al., 2005b ) and leaching of core metals into the culture medium (Derfus et al., 2004) . Metal leaching from the core is an unlikely mechanism of toxicity in the present study because core composition was controlled (i.e. these QDs differed only in surface coating) and the CdSe core of all QDs were ''capped'' with ZnS, which has been shown to attenuate leaching (Derfus et al., 2004) . Oxidative stress as a result of reactive oxygen species production cannot be ruled out, but does not directly address the clear effect of QD coating on HEK viability that we observed. Before this work, inflammatory responses to QDs had not been explored. QDs and other nano-sized structures are expected to have high inflammatory potential owing to a large surface area to volume ratio (Oberdorster et al., 2005) . This expectation is based upon immune responses of the lung following exposure to airborne particulate matter, which has shown the greatest infiltration of immune cells for ultrafine (nano-sized) versus larger particles (Oberdorster, 2001) . Immune responses of skin are substantially mediated by epidermal keratinocytes, which upon activation by environmental stimuli, secrete proinflammatory cytokines (Barker et al., 1991; Nickoloff, 1991) . Previous studies in our laboratory have shown that IL-8 is a suitable biomarker for cutaneous inflammation in response to diverse chemicals and chemical mixtures (Allen et al., 2000 (Allen et al., , 2001 Chou et al., 2002; Chou et al., 2003; Monteiro-Riviere et al., 2003; ) . The cytokines selected for the present study are broad markers for keratinocyte-mediated inflammation. Levels of all cytokines were normalized to the MTT viability data to account for reduced cell number resulting from cytotoxicity. We observed a robust effect of coating on cytokine release in response to QDs. This effect was consistent across two sizes of QDs and for three different cytokines. Carboxylic acidcoated QDs of both sizes increased release of IL-1b, IL-6, and IL-8 2-to 5-fold over 48 hours, whereas PEG-coated QDs exhibited no increase in cytokine release and PEG-aminecoated QDs exhibited only a slight increase in IL-6 and IL-8. Modulatory effects of time and size on cytokine release for carboxylic acid-coated QDs were noted when carboxylic acid-coated QD 565 showed a 2-fold increase in IL-6 and IL-8 release at 24 hours that did not increase between 24 and 48 hours, but carboxylic acid-coated QD 655 did not cause significant elevations in IL-6 and IL-8 until 48 hours, at which time the magnitude of release was similar to that of QD 565. Also, both carboxylic acid-coated QD 565 and QD 655 showed a 2-to 3-fold increase in the release of IL-1b at 24 hours. By 48 hours, however, the magnitude of IL-1b release for QD 655 was 2.5-fold greater than that of QD 565, which remained at levels similar to the 24 hours time point. Thus, a 24 hours delay in maximal cytokine release for carboxylic acid-coated QD 655 relative for QD 565 was observed for all three cytokines. Also of consideration is the contribution of delivery vehicles to the inflammatory response. Although we saw no effects of the QD vehicles used herein on proinflammatory cytokine release, we have observed modulation of multi-walled carbon nanotubesmediated IL-8 release in HEKs when delivered in pluronic surfactant vehicles (Monteiro-Riviere et al., 2005a) . The present study suggests that the surface charge of the QDs, whether cationic or anionic, is an important variable for QD cytotoxicity and inflammation, with the cationic carboxylic acid-coated QDs showing the highest potential. This could be secondary to altered cellular localization of charged QDs or increased sensitivity of target site to these particles. This phenomenon, now recognized by this research, deserves further study. It is also of relevance for risk assessment in the light of evidence that QDs can penetrate the outer stratum corneum barrier of intact skin. Previously, we used these same QDs to show that topically applied QD 565 and QD 655 coated with PEG, PEG-amine, and carboxylic acids localized within the epidermis or dermis by 8 hours for all but carboxylic acid-coated QD 655, which localized primarily in the epidermis by 24 hours. Fluorescence intensity maps indicated a passive mechanism of penetration . Recently, QDs have been shown to penetrate porcine skin within minutes when low frequency sonophoresis is applied (Paliwal et al., 2006) . Although the diffusion cell model utilized in both studies provided evidence that exposure to QDs can result in skin penetration, it does not address whether such exposures would cause skin irritation or damage. When our previous observation that carboxylic acid-coated QDs localize in the epidermis are considered in conjunction with the observation of cellular uptake in the present study, the tendency of carboxylic acid-coated QDs to localize in the epidermis may be secondary to the tendency for these QDs to preferentially accumulate in the keratinocyte. The present, in vitro study was conducted at QD concentrations 50-to 5,000-fold lower than the 1 mM concentration we used for the dermal penetration study. The QDs tested herein are supplied at concentrations of up to 8.7 mM, which corresponds to human exposure concentrations that are up to 400-to 40,000-fold greater than those used in the present study. Thus, the concentrations at which we observed QD uptake, cytotoxic effects, and inflammatory cytokine release are arguably not supraphysiological, but within a reasonable range for human skin exposure to QDs as commercially supplied. Our results indicated potential for QDs coated with carboxylic acids in particular to cause cytotoxicity and cutaneous inflammation in vivo. Again, these are the same QDs in which we had observed primarily epidermal localization in our previous skin penetration study . Cutaneous inflammation can be restricted to the site of entry or, as in the case of topical exposure to JP-8, also result in systemic modulation of immune function (Ullrich, 1999) .
Our observation of QD uptake by HEKs at low, noncytotoxic concentrations for all sizes and coatings begs the question of what the long-term effects of prolonged retention of QDs in HEKs might be. Particularly of importance is that uptake of QDs by HEKs was not selective because QDs were not ''targeted'' for cellular uptake by attachment to targeting peptides or antibodies, yet intracellular and intranuclear QD localization was observed. This suggests that QDs engineered to function as drug delivery vectors or diagnostic agents at other somatic sites may be non-selectively taken up by skin cells, possibly resulting in side effects or cytotoxicity and immunogenicity in skin.
In summary, this study showed a clear role for surface coating in cytotoxicity and immunotoxicity that was consistent across two sizes. This study expanded our previous observations that dermal exposure to QDs results in skin penetration by showing that select QDs may pose an acute dermal hazard of cytotoxicity and inflammation, depending upon surface coating. Cytotoxic and inflammatory effects of QD surface coatings may extend to other families of engineered nanoparticles, which argues for the utility of QDs as important models for toxic responses of skin to nanoparticles with industrial and medical applications.
MATERIALS AND METHODS
Quantum dots
QDs with a CdSe core and ZnS shell of two different sizes were obtained from Quantum Dot Corporation/Invitrogen (Hayward, CA). QDs with fluorescence emission maxima at 565 nm (QD 565) have a spherical core/shell with a diameter of 4.6 nm. QDs with emission maxima at 655 nm (QD 655) have an ellipsoid core/shell with diameters of 6 nm (minor axis) by 12 nm (major axis) (Quantum Dot Corporation, 2005, personal communication) . Each size was obtained with three different surface coatings: PEG, PEG-amine, or polyacrylic acid (carboxylic acids). These coatings are, respectively, neutral, positive, or negatively charged as supplied and at physiological pH. The hydrodynamic diameters of QD 565 as supplied were 35 nm (PEG), 15 nm (PEG-amine), and 14 nm (carboxylic acid). The hydrodynamic diameters (major axis) of QD 655 were 45 nm (PEG), 20 nm (PEG-amine), and 18 nm (carboxylic acid) (Quantum Dot Corporation, 2005, personal communication Dual label samples containing both QD 565 and QD 655 for live cell confocal studies were prepared to minimize the possibility of coagglomeration. QDs were individually diluted in borate buffer vehicle of the appropriate pH and added to KGM-2 to a final concentration of 4 nM. Equal volumes of 4 nM QD 565 and QD 655 with the same surface coating (PEG, carboxylic acids, or PEGamines) were mixed to a final concentration of 2 nM each of QD565 and QD 655. The medium in 35 mm glass bottom culture dishes was replaced with 2 ml of KGM-2 containing the borate buffer vehicle controls or 2 nM QD 565 and QD 655 and incubated for 24 hours before live cell confocal imaging.
HEKs were plated in 25 cm 2 flasks for TEM. Cells were treated with 2 nM QD 565 or QD 655 of each coating or with borate buffer vehicle controls for 24 hours before processing for TEM.
Laser scanning confocal microscopy of QDs in live HEKs
After 24 hours of dosing with QDs, 35 mm culture dishes were rinsed three times with 2 ml of HBSS and the medium replaced with 2 ml pre-warmed KGM-2. 
TEM of QDs in HEKs
After 24 hours incubation with 2 nM QDs, medium was removed, cells were rinsed three times with two volumes of HBSS, and fixed in Trump's fixative at 41C. HEKs were harvested by scraping into 1.5 ml microfuge tubes followed by centrifugation at 14,000 Â g. Cell pellets were embedded in 3% agar and post-fixed for 1 hour at 41C in 1% osmium tetroxide. Samples were dehydrated in increasing concentrations of ethanol, cleared in acetone, and embedded in Spurr's resin. Thin sections were mounted on copper grids and examined on a Phillips Em208S TEM. Imaging data represent two separate experiments of 1-2 replicates for each QD size and coating.
MTT cell viability assays
An MTT assay was used to assess cell viability after 24 or 48 hours of QD treatment. Cell culture medium containing QDs was removed and 200 ml of 0.5 mg/ml 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (Sigma-Aldrich, St Louis, MO) in KGM-2 was added to QDs and vehicle-treated wells. KGM-2 alone was added to duplicate control wells that contained vehicle-treated cells. HEKs were returned to the incubator for 3 hours. At the end of the incubation period, the medium was removed and HEKs were rinsed with 200 ml of HBSS for 2 minutes. The HBSS was removed by aspiration, and 100 ml of 70% isopropanol was added to each well and incubated for 60 minutes on a rotating platform to dissolve the MTT. Microplates were read at 550 nm in a Multiskan microplate spectrophotometer (Thermo LabSystems, Milford, MA) equipped with Ascent Software (version 2.6). The average background absorbance from control wells (KGM-2 without added MTT) was subtracted from MTT-treated samples and data were plotted as a percentage of the appropriate vehicle-treated control using Prism v. 4 software (Graph Pad Inc., San Diego, CA). Five replicates per data point were used for all treatments. Data are expressed as the means and SEs of two experiments (5% (v/v) water versus borate vehicle controls) or 4-6 experiments (QDs versus the appropriate borate vehicle-treated controls).
Cytokine release assays
Twenty-four hours after the addition of QDs to 96-well microplates (N ¼ 5 wells per treatment point), the culture medium was removed, pooled into a microfuge tube, and frozen at À801C until assayed. On the day of the assay, samples were thawed and 50 ml of each sample added (in duplicate) to a singleplex ELISA plate for human IL-8 and a multiplex ELISA plate for human IL-1b, IL-6, IL-10, and tumor necrosis factor-a (BioPlex Cytokine Assays, BioRad Laboratories, Hercules, CA) and the ELISA performed according to the manufacturer's instructions. Samples were read on a BioPlex System (BioRad/Luminex) equipped with BioPlex software (version 4.0). Unknowns were quantified by linear regression to logarithmic standard curves. Cytokine levels were normalized relative to MTT absorbance. Data were expressed as fold over that of controls receiving the appropriate boric acid vehicle using Prism v. 4 software (Graph Pad Inc., San Diego, CA). Data are expressed as the means and standard errors of two experiments (5% (v/v) water versus borate vehicle-treated controls) or 4-5 experiments (QDs versus the appropriate borate vehicle controls).
Statistical analysis
A Kruskal-Wallis nonparametric analysis of variance was used to compare vehicle-treated cells to cells treated with water for cell viability and cytokine release assays. A one-way analysis of variance was used to compare the effect of concentration on cell viability and inflammatory cytokine release for QDs with size, surface coating, and time held constant. Significant differences were identified via a post hoc Tukey's test. An effect of time on cell viability and inflammatory cytokine release for each size/shape with surface coating and concentration held constant was identified by using a one-way analysis of variance followed by a post hoc Tukey's test. An effect of size/shape was similarly determined for the cell viability and cytokine release data by holding concentration and time constant. Significance for all values was set at Po0.05. All statistical analysis was performed using Prism v. 4 software.
